Reviewed,
UniProtKB/Swiss-Prot O35987 (NSF1C_RAT)
Last modified
June 16, 2009.
Version 81.
History...
Clusters with 100%,
90%,
50% identity |
Documents (2) |
Third-party data |
Customize display | text xml rdf/xml gff fasta |
Names and origin
| Protein names | Recommended name: NSFL1 cofactor p47 Alternative name(s): p97 cofactor p47 XY body-associated protein XY40 | ||
| Gene names |
| ||
| Organism | Rattus norvegicus (Rat) | ||
| Taxonomic identifier | 10116 [NCBI] | ||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Glires › Rodentia › Sciurognathi › Muroidea › Muridae › Murinae › Rattus |
Protein attributes
| Sequence length | 370 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is not processed. |
| Protein existence | Evidence at protein level. |
General annotation (Comments)
| Function | Reduces the ATPase activity of VCP. Necessary for the fragmentation of Golgi stacks during mitosis and for VCP-mediated reassembly of Golgi stacks after mitosis. May play a role in VCP-mediated formation of transitional endoplasmic reticulum (tER). Ref.2 Ref.7 Ref.9 Ref.11 |
| Subunit structure | Part of a ternary complex containing STX5A, NSFL1C and VCP. NSFL1C forms a homotrimer that binds to one end of a VCP homohexamer. The complex binds to membranes enriched in phosphatidylethanolamine-containing lipids and promotes Golgi membrane fusion. Interaction with VCIP135 leads to dissociation of the complex via ATP hydrolysis by VCP. Binds ubiquitin and mono-ubiquitinated proteins via its N-terminal UBA-like domain when bound to VCP. |
| Subcellular location | Nucleus. Golgi apparatus › Golgi stack. Note: Predominantly nuclear in interphase cells. Bound to the axial elements of sex chromosomes in pachytene spermatocytes. A small proportion of the protein is cytoplasmic, associated with Golgi stacks. Ref.2 Ref.5 Ref.13 |
| Tissue specificity | Highly expressed in heart, brain, spleen, lung, liver, muscle, kidney and testis. Ref.2 Ref.5 Ref.1 |
| Developmental stage | Highly expressed in pachytene spermatocytes during spermatogenesis. |
| Post-translational modification | Phosphorylated during mitosis. Phosphorylation inhibits interaction with Golgi membranes and is required for the fragmentation of the Golgi stacks during mitosis. Ref.13 Ref.14 Ref.15 |
| Sequence similarities | Belongs to the NSFL1C family. Contains 1 SEP domain. Contains 1 UBX domain. |
Ontologies
| Keywords | |
|---|---|
| Cellular component | Golgi apparatus Nucleus |
| Ligand | Lipid-binding |
| PTM | Phosphoprotein |
| Technical term | 3D-structure Direct protein sequencing |
| Gene Ontology (GO) | |
| Biological process | Golgi organization Ref.10 Inferred from physical interaction. Source: RGD membrane fusion Ref.10Inferred from direct assay. Source: RGD |
| Cellular component | Golgi stack Inferred from electronic annotation. Source: UniProtKB-SubCell nucleusInferred from electronic annotation. Source: UniProtKB-SubCell |
| Molecular function | lipid binding Inferred from electronic annotation. Source: UniProtKB-KW protein binding Ref.2Inferred from physical interaction. Source: IntAct |
| Complete GO annotation... | |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | |||||||||||||||||||||||||||||||||||||||||||
Molecule processing | ||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 370 | 370 | NSFL1 cofactor p47 | PRO_0000210990 | ||||||||||||||||||||||||||||||||||||||||||||
Regions | ||||||||||||||||||||||||||||||||||||||||||||||||
| Domain | 179 – 244 | 66 | SEP | |||||||||||||||||||||||||||||||||||||||||||||
| Domain | 291 – 368 | 78 | UBX | |||||||||||||||||||||||||||||||||||||||||||||
| Motif | 109 – 115 | 7 | Nuclear localization signal | |||||||||||||||||||||||||||||||||||||||||||||
| Motif | 172 – 175 | 4 | Nuclear localization signal | |||||||||||||||||||||||||||||||||||||||||||||
Amino acid modifications | ||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 74 | 1 | Phosphoserine By similarity | |||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 114 | 1 | Phosphoserine Ref.14 Ref.15 | |||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 140 | 1 | Phosphoserine; by CDC2 | |||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 165 | 1 | Phosphoserine By similarity | |||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 167 | 1 | Phosphotyrosine By similarity | |||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 176 | 1 | Phosphoserine Ref.15 | |||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 272 | 1 | Phosphoserine By similarity | |||||||||||||||||||||||||||||||||||||||||||||
Experimental info | ||||||||||||||||||||||||||||||||||||||||||||||||
| Mutagenesis | 41 | 1 | F → A: Reduces ubiquitin binding and Golgi reassembly. Ref.11 | |||||||||||||||||||||||||||||||||||||||||||||
| Mutagenesis | 57 | 1 | T → A: No effect on phosphorylation. Ref.13 | |||||||||||||||||||||||||||||||||||||||||||||
| Mutagenesis | 112 | 1 | K → T: Strongly reduces nuclear location. Ref.13 | |||||||||||||||||||||||||||||||||||||||||||||
| Mutagenesis | 114 | 1 | S → A: No effect on phosphorylation. Ref.13 | |||||||||||||||||||||||||||||||||||||||||||||
| Mutagenesis | 140 | 1 | S → A: Abolishes phosphorylation by CDC2. Ref.13 | |||||||||||||||||||||||||||||||||||||||||||||
| Mutagenesis | 140 | 1 | S → D: Strongly reduces binding to Golgi membranes. Ref.13 | |||||||||||||||||||||||||||||||||||||||||||||
| Mutagenesis | 173 | 1 | R → T: Strongly reduces nuclear location. Ref.13 | |||||||||||||||||||||||||||||||||||||||||||||
| Mutagenesis | 272 | 1 | S → A: No effect on phosphorylation. Ref.13 | |||||||||||||||||||||||||||||||||||||||||||||
| Mutagenesis | 301 | 1 | R → A: Reduced interaction with VCP. Ref.17 | |||||||||||||||||||||||||||||||||||||||||||||
| Mutagenesis | 342 – 345 | 4 | TFPN → AG: Strongly reduced interaction with VCP. Ref.17 | |||||||||||||||||||||||||||||||||||||||||||||
| Mutagenesis | 343 | 1 | F → S: Reduced interaction with VCP. Ref.17 | |||||||||||||||||||||||||||||||||||||||||||||
| Mutagenesis | 345 | 1 | N → A: Reduced interaction with VCP. Ref.17 | |||||||||||||||||||||||||||||||||||||||||||||
Secondary structure | ||||||||||||||||||||||||||||||||||||||||||||||||
Helix Strand Turn | ||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 4 – 15 | 12 | ||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 20 – 29 | 10 | ||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 35 – 43 | 9 | ||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 181 – 187 | 7 | ||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 190 – 192 | 3 | ||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 198 – 200 | 3 | ||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 206 – 215 | 10 | ||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 221 – 224 | 4 | ||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 227 – 229 | 3 | ||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 232 – 237 | 6 | ||||||||||||||||||||||||||||||||||||||||||||||
| Turn | 239 – 241 | 3 | ||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 275 – 286 | 12 | ||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 298 – 302 | 5 | ||||||||||||||||||||||||||||||||||||||||||||||
| Turn | 303 – 306 | 4 | ||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 307 – 311 | 5 | ||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 318 – 328 | 11 | ||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 331 – 333 | 3 | ||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 337 – 341 | 5 | ||||||||||||||||||||||||||||||||||||||||||||||
| Turn | 342 – 345 | 4 | ||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 355 – 358 | 4 | ||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 364 – 369 | 6 | ||||||||||||||||||||||||||||||||||||||||||||||
Sequences
| ||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Molecular characterization and expression pattern of XY body-associated protein XY40 of the rat." Alsheimer M., Imamichi Y., Heid H., Benavente R. Chromosoma 106:308-314(1997) [PubMed: 9297509] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA], PROTEIN SEQUENCE OF 200-209; 283-292 AND 323-328, TISSUE SPECIFICITY. Strain: Wistar. Tissue: Spermatocyte. |
| [2] | "p47 is a cofactor for p97-mediated membrane fusion." Kondo H., Rabouille C., Newman R., Levine T.P., Pappin D., Freemont P., Warren G. Nature 388:75-78(1997) [PubMed: 9214505] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA], PROTEIN SEQUENCE OF 11-22; 94-101; 157-172; 189-214; 260-282; 323-346 AND 357-368, MASS SPECTROMETRY, FUNCTION, INTERACTION WITH VCP, SUBCELLULAR LOCATION, TISSUE SPECIFICITY. Tissue: Liver. |
| [3] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed: 15489334] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. Tissue: Lung. |
| [4] | Lubec G., Chen W.-Q. Submitted (APR-2007) to UniProtKB Cited for: PROTEIN SEQUENCE OF 200-214 AND 283-301, MASS SPECTROMETRY. Strain: Sprague-Dawley. Tissue: Hippocampus. |
| [5] | "Meiosis-specific protein selectively associated with sex chromosomes of rat pachytene spermatocytes." Smith A., Benavente R. Proc. Natl. Acad. Sci. U.S.A. 89:6938-6942(1992) [PubMed: 1495983] [Abstract] Cited for: TISSUE SPECIFICITY, SUBCELLULAR LOCATION. |
| [6] | "Syntaxin 5 is a common component of the NSF- and p97-mediated reassembly pathways of Golgi cisternae from mitotic Golgi fragments in vitro." Rabouille C., Kondo H., Newman R., Hui N., Freemont P., Warren G. Cell 92:603-610(1998) [PubMed: 9506515] [Abstract] Cited for: INTERACTION WITH STX5A. |
| [7] | "The p47 co-factor regulates the ATPase activity of the membrane fusion protein, p97." Meyer H.H., Kondo H., Warren G. FEBS Lett. 437:255-257(1998) [PubMed: 9824302] [Abstract] Cited for: FUNCTION. |
| [8] | "A complex of mammalian ufd1 and npl4 links the AAA-ATPase, p97, to ubiquitin and nuclear transport pathways." Meyer H.H., Shorter J.G., Seemann J., Pappin D., Warren G. EMBO J. 19:2181-2192(2000) [PubMed: 10811609] [Abstract] Cited for: INTERACTION WITH VCP. |
| [9] | "Role of p97 and syntaxin 5 in the assembly of transitional endoplasmic reticulum." Roy L., Bergeron J.J.M., Lavoie C., Hendriks R., Gushue J., Fazel A., Pelletier A., Morre D.J., Subramaniam V.N., Hong W., Paiement J. Mol. Biol. Cell 11:2529-2542(2000) [PubMed: 10930451] [Abstract] Cited for: FUNCTION. |
| [10] | "Phospholipid species act as modulators in p97/p47-mediated fusion of Golgi membranes." Pecheur E.-I., Martin I., Maier O., Bakowsky U., Ruysschaert J.-M., Hoekstra D. Biochemistry 41:9813-9823(2002) [PubMed: 12146947] [Abstract] Cited for: INTERACTION WITH MEMBRANES. |
| [11] | "Direct binding of ubiquitin conjugates by the mammalian p97 adaptor complexes, p47 and Ufd1-Npl4." Meyer H.H., Wang Y., Warren G. EMBO J. 21:5645-5652(2002) [PubMed: 12411482] [Abstract] Cited for: FUNCTION, MUTAGENESIS OF PHE-41. |
| [12] | "VCIP135, a novel essential factor for p97/p47-mediated membrane fusion, is required for Golgi and ER assembly in vivo." Uchiyama K., Jokitalo E., Kano F., Murata M., Zhang X., Canas B., Newman R., Rabouille C., Pappin D., Freemont P., Kondo H. J. Cell Biol. 159:855-866(2002) [PubMed: 12473691] [Abstract] Cited for: INTERACTION WITH VCIP135. |
| [13] | "The localization and phosphorylation of p47 are important for Golgi disassembly-assembly during the cell cycle." Uchiyama K., Jokitalo E., Lindman M., Jackman M., Kano F., Murata M., Zhang X., Kondo H. J. Cell Biol. 161:1067-1079(2003) [PubMed: 12810701] [Abstract] Cited for: PHOSPHORYLATION, MUTAGENESIS OF THR-57; LYS-112; SER-114; SER-140; ARG-173 AND SER-272, SUBCELLULAR LOCATION. |
| [14] | "Phosphoproteomic analysis of rat liver by high capacity IMAC and LC-MS/MS." Moser K., White F.M. J. Proteome Res. 5:98-104(2006) [PubMed: 16396499] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-114, MASS SPECTROMETRY. Tissue: Liver. |
| [15] | "Quantitative phosphoproteomics of vasopressin-sensitive renal cells: regulation of aquaporin-2 phosphorylation at two sites." Hoffert J.D., Pisitkun T., Wang G., Shen R.-F., Knepper M.A. Proc. Natl. Acad. Sci. U.S.A. 103:7159-7164(2006) [PubMed: 16641100] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-114 AND SER-176, MASS SPECTROMETRY. Tissue: Kidney. |
| [16] | "Solution structure and interaction surface of the C-terminal domain from p47: a major p97-cofactor involved in SNARE disassembly." Yuan X., Shaw A., Zhang X., Kondo H., Lally J., Freemont P.S., Matthews S. J. Mol. Biol. 311:255-263(2001) [PubMed: 11478859] [Abstract] Cited for: STRUCTURE BY NMR OF 282-370, INTERACTION WITH VCP. |
| [17] | "Structural basis of the interaction between the AAA ATPase p97/VCP and its adaptor protein p47." Dreveny I., Kondo H., Uchiyama K., Shaw A., Zhang X., Freemont P.S. EMBO J. 23:1030-1039(2004) [PubMed: 14988733] [Abstract] Cited for: X-RAY CRYSTALLOGRAPHY (2.9 ANGSTROMS) OF 244-370, INTERACTION WITH VCP, MUTAGENESIS OF ARG-301; 342-THR--ASN-345; PHE-343 AND ASN-345. |
| [18] | "Structure, dynamics and interactions of p47, a major adaptor of the AAA ATPase, p97." Yuan X., Simpson P., McKeown C., Kondo H., Uchiyama K., Wallis R., Dreveny I., Keetch C., Zhang X., Robinson C., Freemont P., Matthews S. EMBO J. 23:1463-1473(2004) [PubMed: 15029246] [Abstract] Cited for: STRUCTURE BY NMR OF 1-46 IN COMPLEX WITH UBQUITIN, STRUCTURE BY NMR OF 171-246, INTERACTION WITH VCP. |
Cross-references
Sequence databases | |||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Y10769 mRNA. Translation: CAA71742.1. AB002086 mRNA. Translation: BAA21659.1. BC072464 mRNA. Translation: AAH72464.1. | |||||||||||||||||||||||||||||||||||||
| IPI | IPI00214262. | ||||||||||||||||||||||||||||||||||||
| RefSeq | NP_114187.1. | ||||||||||||||||||||||||||||||||||||
| UniGene | Rn.2771 | ||||||||||||||||||||||||||||||||||||
3D structure databases | |||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||
| SMR | O35987. Positions 171-270. | ||||||||||||||||||||||||||||||||||||
| ModBase | Search... | ||||||||||||||||||||||||||||||||||||
Protein-protein interaction databases | |||||||||||||||||||||||||||||||||||||
| IntAct | O35987. 15 interactions. | ||||||||||||||||||||||||||||||||||||
PTM databases | |||||||||||||||||||||||||||||||||||||
| PhosphoSite | O35987. | ||||||||||||||||||||||||||||||||||||
Genome annotation databases | |||||||||||||||||||||||||||||||||||||
| Ensembl | ENSRNOG00000008604. Rattus norvegicus. [Contig view] | ||||||||||||||||||||||||||||||||||||
| GeneID | 83809. | ||||||||||||||||||||||||||||||||||||
| KEGG | rno:83809. | ||||||||||||||||||||||||||||||||||||
Organism-specific databases | |||||||||||||||||||||||||||||||||||||
| RGD | 619952. Nsfl1c. | ||||||||||||||||||||||||||||||||||||
Phylogenomic databases | |||||||||||||||||||||||||||||||||||||
| HOVERGEN | O35987. | ||||||||||||||||||||||||||||||||||||
Gene expression databases | |||||||||||||||||||||||||||||||||||||
| ArrayExpress | O35987. | ||||||||||||||||||||||||||||||||||||
| GermOnline | ENSRNOG00000008604. Rattus norvegicus. | ||||||||||||||||||||||||||||||||||||
Family and domain databases | |||||||||||||||||||||||||||||||||||||
| InterPro | IPR012989. SEP. IPR001012. UBX. [Graphical view] | ||||||||||||||||||||||||||||||||||||
| Pfam | PF08059. SEP. 1 hit. PF00789. UBX. 1 hit. [Graphical view] | ||||||||||||||||||||||||||||||||||||
| SMART | SM00553. SEP. 1 hit. SM00166. UBX. 1 hit. [Graphical view] | ||||||||||||||||||||||||||||||||||||
| PROSITE | PS51399. SEP. 1 hit. PS50033. UBX. 1 hit. [Graphical view] | ||||||||||||||||||||||||||||||||||||
| ProtoNet | Search... | ||||||||||||||||||||||||||||||||||||
Other Resources | |||||||||||||||||||||||||||||||||||||
| NextBio | 616417. | ||||||||||||||||||||||||||||||||||||
Entry information
| Entry name | NSF1C_RAT | ||||||||
| Accession | Primary (citable) accession number: O35987 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation project | HPI (Human Proteome Initiative) | ||||||||
Relevant documents
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |
| SIMILARITY comments Index of protein domains and families |

Clusters with


